The InBody BWA ON Lymphedema Clinical Research Study
Consider Enrolling in a Clinical Trial for breast cancer survivors who are at risk of developing Lymphedema Today!
The InBody BWA ON Lymphedema Clinical Research Study
Consider Enrolling in a Clinical Trial for breast cancer survivors who are at risk of developing Lymphedema Today!
About The InBody BWA ON Study
The InBody BWA ON research study is evaluating if the use of a body composition assessment device, called the InBody BWA ON, is effective in detecting and monitoring lymphedema in adults, who have had breast cancer-related surgery within the last 12 months prior to enrollment.
The InBody BWA ON device will be given for at-home use to all adults who participate, and is used twice daily through the study, in the morning and evening. Participants will be asked to attend 5 in-clinic visits throughout the study. The study will last approximately 12 months, including the initial visit and follow-up visits.
Participants who successfully enroll into the study will be given the InBody BWA ON device for use in the comfort of their own home for the entirety of the study. If appropriate, some participants will be allowed to continue using the at-home device after the study is completed.
Study Criteria
If you, or someone you know, is interested in enrolling in this study, you or they may be eligible if you:
Are an adult aged 18 or older
Have a medical diagnosis of unilateral (on one side) breast cancer
Have had breast cancer-related surgery within the last 12 months prior to enrollment
*Other eligibility criteria apply. Participants receive in-home BWA ON device at no cost. Compensation for study-related time and travel may be provided.
Participation Overview
This study’s main purpose it to evaluate if the use of a body composition assessment device, called the InBody BWA ON, is effective in detecting and monitoring lymphedema in adults who have had breast cancer-related surgery within the last 12 months prior to enrollment. All participants enrolled in this study will be supplied the InBody BWA ON device for use in the comfort of their own home, to be used twice daily (morning and evening) every day through the study.
All participants who are eligible and successfully enroll in this study will participate for up to 12 months. This includes an initial screening visit to determine if you are eligible for the study. This visit is when the participants receive the InBody BWA ON device and are shown how to use it. Visit 2 occurs at month 3 and involves follow-up surveillance for standard of care with the InBody 770 and circumference tape. OT/PT treatment is included if needed. The last 3 visits occur at month 6, month 9, and month 12 respectively, and include standard of care for complete decongestive therapy, with InBody 770 testing and circumference tape measurements.
Refer a Friend
Do you know someone age 18 or older who has had breast cancer related surgery in the last 12 months? They may be eligible to participate in this clinical study. Consider sharing information with them about how they can learn more.